FDA Brief

Warning letters Drugs

FDA warning letter to

Beach Weekend Management LLC dba Nic and Jet Fuel

MediumIssued Feb 5Posted Feb 10Center for Drug Evaluation and Research (CDER)

FDA told Nic and Jet Fuel its nicotine energy drinks are unapproved new drugs sold with drug-like claims.

What happened

FDA reviewed the company's website, nicandjetfuel.com, in November 2025 and found "Nicotina Energy Citrus Surge Lite 3 MG" and "Nicotina Energy Grapefruit Spark Lite 3 MG" offered for sale in the United States. Product pages and blog posts said the drinks sharpen focus, lift mood, improve memory and may help with ADHD, Parkinson's, Alzheimer's, depression and anxiety. The letter describes a website review only; no inspection is mentioned.

What FDA found

  1. The website statements about focus, mood, memory and disease make these drinks drugs in FDA's view, because they are meant to affect the body or treat disease.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1); 21 CFR 201.128
  2. FDA calls them new drugs, meaning they are not generally recognized as safe and effective for those uses, and no FDA-approved application is in effect for them.

    FD&C Act sections 201(p) and 505(a), 21 U.S.C. 321(p) and 355(a)
  3. Selling or shipping them across state lines without that approval is illegal.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
  4. If the company changes the products so they are no longer drugs, they may count as tobacco products, which need their own premarket authorization order.

    FD&C Act section 910(a), 21 U.S.C. 387j(a)
  5. If sold as a food or beverage, any ingredient not approved as a food additive would make the product adulterated, meaning illegal to sell.

    FD&C Act section 402(a)(2)(C), 21 U.S.C. 342(a)(2)(C)

What FDA wants

FDA tells the company to reply in writing within 15 working days to CDER's Office of Unapproved Drugs and Labeling Compliance, listing the specific steps taken to fix the violations and prevent them from recurring. If the company believes the products are lawful, it must send its reasoning and supporting information.

Who should pay attention

  • online sellers of nicotine or energy drinks that make cognitive or health claims
  • retailers and distributors that stock nicotine beverage products
  • brands whose marketing or blog copy cites benefits for ADHD, Parkinson's or anxiety

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk